SIRT7 and Hepatic steatosis: Systemic suppression of SIRT7 could recapitulate phenotypes observed in knockout animal models, including metabolic dysfunctions (e.g., hepatic steatosis), osteopenia, inflammatory disorders, cardiomyopathy, and other abnormalities, as described above [7,8,9].